Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
236,234,693
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
15,103,338
-
Shares change
-
+2,477,404
-
Total reported value, excl. options
-
$145,886,918
-
Value change
-
+$23,189,587
-
Put/Call ratio
-
99%
-
Number of buys
-
50
-
Number of sells
-
26
-
Price
-
$9.66
Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q3 2015
As of 30 Sep 2015 Akebia Therapeutics, Inc. - Common Stock (AKBA) had 94 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 15,103,338 shares of stock of the company.
Largest 10 holders included EAGLE ASSET MANAGEMENT INC, FMR LLC, Novo A/S, BlackRock Fund Advisors, VANGUARD GROUP INC, Visium Asset Management, LP, BlackRock Institutional Trust Company, N.A., STIFEL FINANCIAL CORP, Marshall Wace LLP, and BANK OF AMERICA CORP /DE/.
This table shows 94 institutional shareholders of the security as of 30 Sep 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.